Propanc Biopharma Potential Upside
| PPCB Stock | | | USD 0.13 0.01 8.33% |
Propanc Biopharma potential upside lookup summarizes this and related technical indicators for Propanc Biopharma Common. Some instruments may have limited coverage due to data differences;
Equity Screeners lists screening tools. Propanc Biopharma has a market cap of 2.22 M, ROE of -18.12%. Use
Your Equity Center to explore allocation context. This includes a position in Propanc Biopharma Common across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in unemployment.
Propanc Biopharma Common has current Potential Upside of 7.14. Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument.
Potential Upside | = | 1PM2PM |
| = | 7.14 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Propanc Biopharma Potential Upside Peers Comparison
Propanc Potential Upside Relative To Other Indicators
Propanc Biopharma Common is rated
below average in potential upside among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
8.15 of Maximum Drawdown per Potential Upside. At
8.15 , Propanc Biopharma Common's Maximum Drawdown-to-Potential Upside multiple reflects the spread between these metrics
Unlike using an educated guess on how high a stock could go calculate potential upside as the greater the potential dollar or percentage rise, the bigger the upside for the investment. Potential Upside is the reciprocal of the Value At Risk measure and can be interpreted as return on an investment relative to minimal acceptable return.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.